Login / Signup

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis.

Jeayeon ParkYun Bin LeeYunmi KoYoungsu ParkHyunjae ShinMoon Haeng HurMin Kyung ParkDae-Won LeeEun Ju ChoKyung-Hun LeeJeong-Hoon LeeSu Jong YuTae-Yong KimYoon Jun KimTae-You KimJung-Hwan Yoon
Published in: Journal of liver cancer (2024)
The effectiveness of atezolizumab plus bevacizumab and lenvatinib was comparable for the treatment of HCC with PVTT.
Keyphrases
  • metastatic colorectal cancer
  • randomized controlled trial
  • systematic review
  • pulmonary embolism
  • smoking cessation